I for one thought we'd be gone in February 2024.
I just figured that there's no way that a big pharma company will let this get away.
And the more I read, the more I note that big Pharma want late stage companies.
But I just still cant see how anyone would wait until a successful ph3.
I just dont know where the trigger point is now.
Is it an FDA agreement of endpoints and a structured beginning to a Ph3 trial?
We have the cash. So there's just no road blocks other than the endpoints being argued and agreed to.
I want the cash. But geez, there's families that are just waiting for these trials to get going. Because its going to be 4 years until they can get treatment after its started (if it passes).
That would be doing my head in as a parent.
- Forums
- ASX - By Stock
- NEU
- Ann: Update - Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Ann: Update - Notification of buy-back - NEU, page-64
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 14.030 |
1 | 500 | 14.000 |
1 | 357 | 13.970 |
1 | 30 | 13.900 |
1 | 700 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 2920 | 1 |
14.300 | 1000 | 1 |
14.380 | 72 | 1 |
14.400 | 1000 | 1 |
14.460 | 434 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online